Sinopharm Group Co. Ltd. (SHTDY)
OTC: SHTDY
· Real-Time Price · USD
12.51
0.19 (1.50%)
At close: Aug 15, 2025, 3:55 PM
12.48
-0.27%
After-hours: Aug 15, 2025, 03:17 PM EDT
Sinopharm Cash Flow Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 8.65B | 8.88B | 9.05B | 8.77B | 8.94B | 8.69B | 8.53B | 7.91B | 7.87B | 7.97B | 7.76B | 7.93B | 7.87B | 7.59B |
Depreciation & Amortization | 4.47B | 4.24B | 4.24B | 4B | 4.1B | 4B | 4B | 3.78B | 3.9B | 3.78B | 3.78B | 3.47B | 3.76B | 3.47B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.57M | 18.57M |
Other Working Capital | 3.42B | 3.71B | 3.71B | -5.91B | 3.14B | -5.91B | -5.91B | 421.26M | -2.28B | 421.26M | 421.26M | 3.77B | 2.33B | 3.77B |
Other Non-Cash Items | 6.54B | 7.95B | 14.56B | 14.66B | 36.52B | 18.78B | 23.14B | 27.45B | 20.8B | 26.55B | 28.41B | 17.95B | 35.06B | 19.44B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -164.16M | -10.69B | -10.69B | -14.7B | -37.63B | -14.7B | -14.7B | -30.64B | -29.79B | -30.64B | -30.64B | -22.54B | -35.71B | -22.54B |
Operating Cash Flow | 19.51B | 10.39B | 17.17B | 12.72B | 11.93B | 16.76B | 20.96B | 8.51B | 2.78B | 7.66B | 9.31B | 6.79B | 10.98B | 7.95B |
Capital Expenditures | -2.5B | -2.27B | -2.2B | -2.16B | -2.21B | -2.34B | -2.36B | -2.14B | -2.15B | -2.13B | -2.07B | -2.13B | -2.1B | -1.96B |
Cash Acquisitions | -141.58M | -136.39M | -65.5M | -341.34M | -205.17M | -368.45M | -342.31M | -397.96M | -426.99M | -308.36M | -497.22M | -332.89M | -2.19B | -2.07B |
Purchase of Investments | 283.85M | 283.85M | 283.85M | 300.81M | 78.46M | 78.46M | 78.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -40.47M | -40.47M | -40.47M | 46.19M | 73.18M | 73.18M | 73.18M | 137.02M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.71B | 104.73M | 127.04M | -407.86M | -190.7M | -354.5M | -692.3M | 327.96M | 1.61B | 869.26M | 1.3B | 998.22M | 186.01M | 1.59B |
Investing Cash Flow | -3.16B | -1.1B | -944.53M | -2.56B | -2.8B | -3.26B | -3.59B | -2.42B | -964.24M | -1.57B | -1.27B | -1.46B | -4.11B | -2.44B |
Debt Repayment | 1.5B | 1.39B | 1.48B | 9.23B | 1.73B | 3.69B | 2.92B | 2.14B | 3.78B | -1.61B | -6.54B | -8.26B | -4.08B | -10.23B |
Common Stock Repurchased | -59.88M | -13.9M | -13.9M | -13.9M | -13.9M | -64.63M | -64.63M | -64.63M | -64.63M | n/a | n/a | n/a | n/a | -163.12M |
Dividend Paid | -9.22B | -9.22B | -9.28B | -9.31B | -9.11B | -9.11B | -8.97B | -8.54B | -7.93B | -7.93B | -7.68B | -7.9B | -7.83B | -9.17B |
Other Financial Acitivies | -2.39B | -1.53B | -2.6B | -8.43B | -7.45B | -6.76B | -7.53B | -5.55B | -4.58B | -3.53B | -5.22B | -1.31B | -5.13B | -1.5B |
Financial Cash Flow | -7.39B | -6.6B | -7.64B | -5.72B | -6.91B | -4.31B | -5.69B | -2.12B | -4.04B | -8.31B | -14.69B | -12.27B | -11.85B | -13.2B |
Net Cash Flow | 8.95B | 2.21B | 8.59B | 4.43B | 2.23B | 9.59B | 11.69B | 4B | -2.21B | -2.23B | -6.65B | -6.97B | -4.96B | -7.69B |
Free Cash Flow | 17B | 8.12B | 14.97B | 10.56B | 9.72B | 14.42B | 18.6B | 6.36B | 631.03M | 5.53B | 7.23B | 4.67B | 8.88B | 5.99B |